Shareholder alert: ademi llp investigates disclosure issues involving arca biopharma, inc.'s transaction with oruka

Milwaukee , june 4, 2024 /prnewswire/ -- ademi llp is investigating arca (nasdaq: abio) for possible breaches of fiduciary duty and other violations of law in its transaction with oruka. click here to learn how to join the https://www.ademilaw.com/case/arca-biopharma-inc or call guri ademi toll-free at 866-264-3995.
ABIO Ratings Summary
ABIO Quant Ranking